Cellectis announced the resignation of Bing Wang from his position of the company with immediate effect, and the concomitant appointment of Arthur Stril as interim CFO replacing Mr. Bing Wang. Stril joined Cellectis in 2018 as Vice President, Corporate Development, and was appointed Chief Business Officer in 2020.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLLS:
- Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
- Cellectis reports Q1 EPS (59c), consensus (22c)
- Cellectis Unveils Groundbreaking Gene-Editing Advances
- Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
- Cellectis Unveils Gene Therapy Breakthrough
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue